Involvement of the GABAergic system in PTSD and its therapeutic significance

Junhui Huang, Fei Xu, Liping Yang, Lina Tuolihong, Xiaoyu Wang, Zibo Du, Yiqi Zhang, Xuanlin Yin, Yingjun Li, Kangrong Lu, Wanshan WangFrontiers in Molecular Neuroscience 2023 · DOI

Abstract

The neurobiological mechanism of post-traumatic stress disorder (PTSD) is poorly understood. The inhibition of GABA neurons, especially in the amygdala, is crucial for the precise regulation of the consolidation, expression, and extinction of fear conditioning. The GABAergic system is involved in the pathophysiological process of PTSD, with several studies demonstrating that the function of the GABAergic system decreases in PTSD patients. This paper reviews the preclinical and clinical studies, neuroimaging techniques, and pharmacological studies of the GABAergic system in PTSD and summarizes the role of the GABAergic system in PTSD. Understanding the role of the GABAergic system in PTSD and searching for new drug targets will be helpful in the treatment of PTSD.

Introduction

Post-traumatic stress disorder (PTSD) is a debilitating condition triggered by exposure to traumatic events. While it is characterized by "overactive" fear circuits, the specific molecular failures that allow these responses to persist are not fully understood. Gamma-aminobutyric acid (GABA), the primary inhibitory neurotransmitter in the central nervous system, plays a critical role in regulating fear memory. This review synthesizes preclinical and clinical data to demonstrate that PTSD is fundamentally characterized by a systemic decline in GABAergic function.

The GABAergic "Brake" and E-I Imbalance

In a healthy brain, GABAergic neurons provide essential "top-down" inhibition, acting as a "brake" that allows fear memories to be extinguished. In PTSD, this system is compromised, leading to an excitation-inhibition (E-I) imbalance. Chronic stress impairs enzymes like GAD67, which converts excitatory glutamate into inhibitory GABA, resulting in a toxic buildup of excitation and a state of permanent hyper-arousal.

Schematic of GABA receptors in the cell membrane before stress.
Schematic of GABA receptors in the cell membrane after stress, showing a reduction in receptor density.

As illustrated above, the transition from a pre-stress to a post-stress state involves a significant reduction in the density of GABA receptors within the neuronal membrane. This downregulation directly contributes to the failure of fear extinction mechanisms, as the brain loses its primary mechanism for dampening traumatic memory signals.

Clinical and Neuroimaging Evidence

Advanced neuroimaging techniques have provided tangible evidence of these deficits in human patients. Positron Emission Tomography (PET) studies consistently show decreased benzodiazepine-GABA receptor binding in key regions such as the prefrontal cortex (PFC), hippocampus, and thalamus. Furthermore, Magnetic Resonance Spectroscopy (MRS) has identified a 30% decrease in the GABA/creatine ratio in the insula of adults with PTSD. Interestingly, some studies show regional heterogeneity, with increased GABA in the dorsolateral PFC, suggesting a complex, region-specific dysregulation of control networks.

Therapeutic Significance and Future Directions

Current pharmacological treatments, such as SSRIs and broad-spectrum benzodiazepines, often fall short. While benzodiazepines provide rapid relief for anxiety, they do not address core symptoms like intrusive thoughts and may even interfere with natural fear extinction if used improperly.

Future research is shifting toward subunit-selective drugs. By targeting specific GABA-A receptor subunits (such as α2, α3, or α5), it may be possible to modulate fear responses more precisely without the sedative and addictive side effects of traditional medications. Additionally, exploring the role of astrocytes in GABA recycling and the interplay with the endocannabinoid system offers promising new avenues for PTSD therapy.

Conclusion

Understanding the GABAergic system's role as a central regulator of fear is vital for developing more effective PTSD treatments. Addressing the systemic decline in GABAergic function and the resulting E-I imbalance remains a primary goal for future clinical interventions.

Summary updated

Abstract

The neurobiological mechanism of post-traumatic stress disorder (PTSD) is poorly understood. The inhibition of GABA neurons, especially in the amygdala, is crucial for the precise regulation of the consolidation, expression, and extinction of fear conditioning. The GABAergic system is involved in the pathophysiological process of PTSD, with several studies demonstrating that the function of the GABAergic system decreases in PTSD patients. This paper reviews the preclinical and clinical studies, neuroimaging techniques, and pharmacological studies of the GABAergic system in PTSD and summarizes the role of the GABAergic system in PTSD. Understanding the role of the GABAergic system in PTSD and searching for new drug targets will be helpful in the treatment of PTSD.
BibTeX
@inproceedings{huang2023involvement,
  author = {Junhui Huang and Fei Xu and Liping Yang and Lina Tuolihong and Xiaoyu Wang and Zibo Du and Yiqi Zhang and Xuanlin Yin and Yingjun Li and Kangrong Lu and Wanshan Wang},
  title = {{Involvement of the GABAergic system in PTSD and its therapeutic significance}},
  booktitle = {Frontiers in Molecular Neuroscience},
  year = {2023},
  doi = {10.3389/fnmol.2023.1052288},
}
Figure